Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Net Cash Flow (2016 - 2025)

Nutex Health's Net Cash Flow history spans 16 years, with the latest figure at $19.5 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 411.52% year-over-year to $19.5 million; the TTM value through Dec 2025 reached $144.9 million, up 677.63%, while the annual FY2025 figure was $144.9 million, 677.63% up from the prior year.
  • Net Cash Flow for Q4 2025 was $19.5 million at Nutex Health, down from $69.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $69.3 million in Q3 2025 and bottomed at -$11.0 million in Q3 2022.
  • The 5-year median for Net Cash Flow is $2.8 million (2021), against an average of $8.0 million.
  • The largest annual shift saw Net Cash Flow plummeted 11317.72% in 2021 before it surged 13240.32% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $1.9 million in 2021, then plummeted by 225.83% to -$2.4 million in 2022, then tumbled by 103.95% to -$4.8 million in 2023, then decreased by 29.92% to -$6.3 million in 2024, then soared by 411.52% to $19.5 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Net Cash Flow are $19.5 million (Q4 2025), $69.3 million (Q3 2025), and $12.0 million (Q2 2025).